Adolore Biotherapeutics, Inc. | WebDisclosure

Basculer en Français

8228	Companies
111072	Keywords
52793	Articles
60962	Press releases

Headlines Articles Press releases Adolore Biotherapeutics, Inc.

Home
Companies
Adolore Biotherapeutics, Inc.

PRESS RELEASE

published on 03/04/2024 at 16:00, 8 months 3 days ago

Adolore BioTherapeutics Announces Issuance of First U.S. Patent Covering CA8* Gene Therapies to Treat Chronic Pain
Adolore BioTherapeutics licenses patent and CA8* gene therapy technology from the University of Miami for opioid-free chronic pain treatment. Company progresses toward clinical testing and commercialization

University Of Miami Adolore BioTherapeutics Chronic Pain Opioid-free Gene Therapy
PRESS RELEASE

published on 01/30/2024 at 16:00, 9 months 8 days ago

Adolore BioTherapeutics to Present at the 5th Annual National Institutes of Health (NIH) HEAL Initiative Scientific Meeting
Adolore BioTherapeutics will present at the 5th Annual NIH HEAL Initiative Scientific Meeting regarding the gene therapy program for chronic pain associated with knee osteoarthritis. The program is supported by NIH/NINDS HEAL UH3 Award

Adolore BioTherapeutics Chronic Pain NIH HEAL Initiative Gene Therapy Osteoarthritis
PRESS RELEASE

published on 12/05/2023 at 16:30, 11 months 2 days ago

Adolore BioTherapeutics Presents Promising Preclinical Data Supporting Its Innovative Gene Therapy to Treat Chronic Pain
Adolore BioTherapeutics presented preclinical data supporting its innovative CA8* gene therapy as a long-acting local analgesic for chronic osteoarthritis knee pain management, aiming to replace opioids

Adolore BioTherapeutics CA8* Gene Therapy Chronic Pain Opioid-free Preclinical Data
PRESS RELEASE

published on 10/11/2023 at 16:00, 1 year ago

Adolore BioTherapeutics to Participate at the Virtual Investor Ask the CEO Conference
PRESS RELEASE

published on 10/03/2023 at 15:15, 1 year 1 month ago

NIN/NINDS HEAL Program Grants Prestigious UH3 Award to the University of Miami, Principal Investigator Roy C. Levitt M.D, to Fund Clinical Development of Adolore BioTherapeutics’ Gene Therapy Program for the Treatment of Chronic Osteoarthritis Knee Pain

Accesswire

Published on 11/08/2024 at 14:00, 38 minutes ago

NOA Lithium Closes $912,596 1st Tranche of the $2.7 Million Non-Brokered Private Placement
Published on 11/08/2024 at 14:00, 38 minutes ago

Ballpoint Marketing - Leader in Handwritten Mail - Acquires a Friendly Competitor: Robot Ink Marketing
Published on 11/08/2024 at 13:30, 1 hour 8 minutes ago

Moderna Receives Health Canada Approval for RSV Vaccine for Adults Aged 60 Years and Older
Published on 11/08/2024 at 13:05, 1 hour 33 minutes ago

Aton Announces Corporate and Operations Update
Published on 11/08/2024 at 13:00, 1 hour 38 minutes ago

Honey Badger Announces Change of Transfer Agent

View all ACCESSWIRE

EQS Group

Published on 11/08/2024 at 14:00, 38 minutes ago

Form 8.3 - Zürcher Kantonalbank: Tritax EuroBox PLC
Published on 11/08/2024 at 12:31, 2 hours 7 minutes ago

Original-Research: ORBIS SE (von GSC Research GmbH): Kaufen
Published on 11/08/2024 at 12:30, 2 hours 8 minutes ago

Holding(s) in Company
Published on 11/08/2024 at 12:25, 2 hours 13 minutes ago

freenet Executive Board formulates financial ambition until 2028 - EBITDA and free cash flow to grow significantly
Published on 11/08/2024 at 12:11, 2 hours 27 minutes ago

PNE AG selected by the European Commission for funding a project to produce hydrogen

Les Echos

Published on 11/08/2024 at 12:32, 2 hours 6 minutes ago

Louis Hachette Group announces the publication of its Information Document for listing on Euronext Growth (Paris)
Published on 11/08/2024 at 12:32, 2 hours 6 minutes ago

Louis Hachette Group annonce la publication de son Document d’Information en vue de sa cotation sur Euronext Growth (Paris)
Published on 11/08/2024 at 12:15, 2 hours 23 minutes ago

Louis Hachette Group announces the publication of its Information Document for listing on Euronext Growth (Paris)
Published on 11/08/2024 at 12:15, 2 hours 23 minutes ago

Louis Hachette Group annonce la publication de son Document d’Information en vue de sa cotation sur Euronext Growth (Paris)
Published on 11/08/2024 at 08:00, 6 hours 38 minutes ago

DAMARTEX / Droits de vote bruts et réels 31 octobre 2024

View all LES ECHOS COMFI WIRE